Association of remdesivir treatment with long-term mortality after COVID-19 hospitalization.

ABSTRACT:

Background

Effectiveness of remdesivir (RDV) treatment on short-term mortality and other outcomes has been well-studied, yet the impact of RDV on long-term outcomes is less well-known. The objective of this study was to determine if inpatient RDV use in survivors of COVID-19 hospitalization is associated with reduced mortality after discharge.

Methods

This is a retrospective observational cohort study of patients hospitalized with COVID-19 between November 2020 and October 2022 in three health systems in Colorado and Utah. Real-world data were identified from electronic health records and state-level vaccination and mortality records. Our primary cohort were patients hospitalized with COVID-19, either treated or not treated with RDV, who survived to hospital discharge. Unadj

SUBMITTER: Agarwal T 

PROVIDER: S-EPMC12560357 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature